New Alzheimer Treatments Struggle to Meet Expectations as Clinical Realities Challenge Medical Hopes
The introduction of monoclonal antibody therapies was heralded as a watershed moment in the decades-long battle against Alzheimer’s disease. For years, the
by 
Josh Weiner
Josh Weiner
